Latest Personalized medicine Stories
DUBLIN, Ohio and CAMBRIDGE, Mass., Sept. 29, 2014 /PRNewswire/ -- Cardinal Health Specialty Solutions and KEW Group, Inc.
LONDON, Sept. 24, 2014 /PRNewswire/ -- In vitro diagnostics are tests that diagnose and prevent diseases, conditions or infections.
AIT, BioVendor and SCIENION signed cooperation agreement for early detection of colon cancer VIENNA, BRNO, Czech Republic and BERLIN, September 24, 2014 /PRNewswire/ --
Leading Oncology Reference Lab to Collaborate in Expanding Medivo’s Lab Value Exchange (LVX) Database of Anonymized Lab Test Results NEW YORK, N.Y.
OMICS Group International is elated to launch its 4th International Conference and Exhibition on Metabolomics and Systems Biology during April 27-29, 2015 at Philadelphia, USA, focusing on the
CAMBRIDGE, Mass., Sept.
DUBLIN, September 19, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/qqjrnh/global_molecular) has announced the addition of the
SAN DIEGO, Sept. 16, 2014 /PRNewswire/ -- Denovo Biopharma, LLC, today announced that it has acquired enzastaurin, a late-stage oncology drug, from Eli Lilly and Company (NYSE: LLY).
- totally perplexed and mixed up.